The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function

European Journal of Immunology

Volumn 41, Issue 8, 2011, Pages 2279-2290

  Herrath, Jessica ^a   Müller, Malin ^a   Amoudruz, Petra ^a   Janson, Peter ^a   Michaëlsson, Jakob ^a   Larsson, Per T ^a   Trollmo, Christina ^a   Raghavan, Sukanya ^a,b   Malmström, Vivianne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Arthritis; Autoimmune disease; FOXP3; Ki67; Methylation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; KI 67 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMETHYLATION; EFFECTOR CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTIGENS, CD2; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; JOINT DISEASES; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RHEUMATIC DISEASES; SYNOVIAL FLUID; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79960735971     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041004     Document Type: Article

References (34)

1. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006. 212: 8-27.
2. Zheng, Y. and Rudensky, A. Y., Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 2007. 8: 457-462.
3. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 2983-2990.
4. Janson, P. C., Winerdal, M. E., Marits, P., Thorn, M., Ohlsson, R. and Winqvist, O., FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One 2008. 3: e1612.
5. Klareskog, L., Catrina, A. I. and Paget, S., Rheumatoid arthritis. Lancet 2009. 373: 659-672.
6. Raghavan, S., Cao, D., Widhe, M., Roth, K., Herrath, J., Engstrom, M., Roncador, G. et al., FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment. Ann. Rheum. Dis. 2009. 68: 1908-1915.
7. + T cells in patients with systemic lupus erythematosus. J. Immunol. 2009. 182: 1689-1695.
8. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum. 2007. 56: 732-742.
9. hi T regulatory cells. Blood. 2006. 108: 253-261.
10. Feldmann, M. and Maini, S. R., Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev. 2008. 223: 7-19.
11. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A. and Mauri, C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004. 200: 277-285.
12. Nadkarni, S., Mauri, C. and Ehrenstein, M. R., Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med. 2007. 204: 33-39.
13. D'Alise, A. M., Auyeung, V., Feuerer, M., Nishio, J., Fontenot, J., Benoist, C. and Mathis, D., The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA. 2008. 105: 19857-19862.
14. + regulatory T cells. J. Immunol. 2008. 181: 7350-7355.
15. -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 2008. 58: 2120-2130.
16. Huehn, J., Polansky, J. K. and Hamann, A., Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 2009. 9: 83-89.
17. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 2003. 33: 215-223.
18. + regulatory T cells. Proc. Natl. Acad. Sci. USA. 2008. 105: 18460-18465.
19. + T cell-mediated suppression by dendritic cells. Science 2003. 299: 1033-1036.
20. Olivito, B., Simonini, G., Ciullini, S., Moriondo, M., Betti, L., Gambineri, E., Cantarini, L. et al., Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J. Rheumatol. 2009. 36: 2017-2024.
21. + regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004. 50: 2775-2785.
22. high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm. Bowel Dis. 2006. 12: 447-456.
23. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T. et al., Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 2007. 13: 423-431.
24. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 2006. 116: 2423-2433.
25. + T cells expressing the FoxP3 transcription factor. Immunity 2009. 30: 899-911.
26. Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L. and Miossec, P., Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999. 42: 963-970.
27. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de Roo, C. J., Joosten, L. A. and van den Berg, W. B., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004. 50: 650-659.
28. Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P. and Sloan-Lancaster, J., LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 2010. 62: 929-939.
29. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 1849-1861.
30. Stummvoll, G. H., DiPaolo, R. J., Huter, E. N., Davidson, T. S., Glass, D., Ward, J. M. and Shevach, E. M., Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008. 181: 1908-1916.
31. + regulatory T cells. J. Biol. Chem. 2010. 285: 7176-7186.
32. Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E. P., Reid, S. P. et al., Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009. 182: 259-273.
33. hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin. Exp. Immunol. 2008. 154: 353-359.
34. Machold, K. P., Landewé, R., Smolen, J. S., Stamm, T. A., van der Heijde, D. M., Verpoort, K. N., Brickmann, K. et al., The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Ann. Rheum. Dis. 2010. 69: 495-502.